RE:RE:RE:RE:RE:RE:RE:RE:RE:Interesting Chart Pattern Shows.......WC,
You are doing the right thing, looking for the weakest link in this story, trying to really understand the company.
As per depth in the company, I would agree, they should look at succession planning sometime down the road as there is no one likely able to steer the ship besides Gilles.
As for resoucres, they did some restructuring earlier in the year and are getting help as needed. Additional resources include the addition of a PGX research scientst, the use of an agency to help negotiate deals, and help on a NASDAQ uplisting. The latter 2 would be to alleviate the workload from Gilles. I'm certain that as the company signs deals, they will beef up the operations and management team.
WIth regards to financings and projects, they have enough working capital for now, Gilles has said that he would prioritize projects as needed. Beyond the raise they did in 2016, they have done well enough with cash flow from their base business to support R&D. Perhaps after a deal is signed they may do a deal with an investment bank for sponsorship and become more shareholder friendly, likely taking advice from the investment banker on increasing the company's visibility on the street.